pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
131
view
list
cards
glycine
no indication
Baylor College of Medicine
1 cat
Marketed
golodirsen
Vyondys 53 (golodirsen)
Duchenne Muscular Dystrophy
$SRPT
Sarepta Therapeutics, Inc.
1 cat
grape powder
no indication
Western New England University
1 cat
iKids-Growth
no indication
← prev
page 6 of 231
next →
Pain
89
Neurology
1
Children’s Hospital of Chongqing Medical University
1 cat
iNKT Cell Immunotherapy
no indication
Zhongshan Hospital
1 cat
influenza vaccine
no indication
Curtin University
1 cat
iruplinalkib
no indication
Qilu Pharmaceutical Co Ltd
1 cat
Marketed
isavuconazonium sulfate
Cresemba (isavuconazonium sulfate)
Aspergillosis
Astellas Pharma US Inc
1 cat
kava
no indication
Mayo Clinic
1 cat
Phase 3
lanifibranor
lanifibranor
Metabolic Dysfunction-Associated Steatohepatitis (MASH or…
Inventiva SA
1 cat
lenvatinib
no indication
Cancer Institute and Hospital Chinese Academy of Medical Sciences
1 cat
Marketed
letermovir
Prevymis (letermovir)
Cytomegalovirus (HHV-5) Infections
Merck Sharp & Dohme Corp (Inactive)
1 cat
mazdutide
no indication
Innovent Biologics Inc
1 cat
mebikar
no indication
Pharmproject
1 cat
micronized progesterone
no indication
University of Utah
1 cat
Phase 2
navlimetostat
navlimetostat
Non-Small Cell Lung Cancer
Bristol-Myers Squibb Co
1 cat
Marketed
norepinephrine
Norepinephrine (norepinephrine [INN])
Hypotension
Long Grove Pharmaceuticals LLC
1 cat
ofatumumab
no indication
Henan Provincial People's Hospital
1 cat
Marketed
olaparib
Lynparza (olaparib)
Epithelial Ovarian Cancer
AstraZeneca Pharmaceuticals LP
1 cat
oleocanthal
no indication
Aristotle University of Thessaloniki
1 cat
ozonated oil
no indication
Nigde Omer Halisdemir University
1 cat
pertuzumab + trastuzumab
no indication
Xijing Hospital
1 cat
pneumococcal (20-valent) vaccine
no indication
Beijing Minhai Biotechnology Co Ltd
1 cat
polyphenol-rich cocoa extract
no indication
German Sport University Cologne
1 cat
pucotenlimab
no indication
Lepu Biopharma Co Ltd
1 cat
Phase 3
raludotatug deruxtecan
raludotatug deruxtecan
Adenocarcinoma Of The Gastroesophageal Junction
Daiichi Sankyo Co Ltd
1 cat
recombinant type III humanized collagen
no indication
Chinese Academy of Medical Sciences Plastic Surgery Hospital
1 cat
risvutatug rezetecan
no indication
Changzhou Hengbang Pharmaceutical Co Ltd
1 cat
Phase 2
samuraciclib
samuraciclib [INN]
Breast Cancer
Carrick Therapeutics Ltd
1 cat
Phase 3
serplulimab
serplulimab
Small-Cell Lung Cancer
Shanghai Henlius Biotech Inc
1 cat
